Copyright
©2010 Baishideng.
World J Gastroenterol. Feb 7, 2010; 16(5): 547-553
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.547
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.547
Study | Adverse effect | Outcomes of therapeutic efficacy | Relief of abdominal pain | Global or clinical improvement | ||||
Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | |
Gilbody et al[24] 2000 | 66/107 | 63/106 | 74/92 | 69/92 | 65/92 | 64/92 | 64/92 | 59/92 |
Inauen et al[25] 1994 | No serious adverse effect | No serious adverse effects | 19/24 | 23/24 | 22/24 | 19/24 |
- Citation: Darvish-Damavandi M, Nikfar S, Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome. World J Gastroenterol 2010; 16(5): 547-553
- URL: https://www.wjgnet.com/1007-9327/full/v16/i5/547.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i5.547